Brendy Van Butsel

Principal Scientist
Sanofi, Ghent, Belgium
Ghent, Oost-Vlaanderen, Belgium

Presentation(s):

• PB0312 - Assessment of post-treatment anti-drug antibodies to caplacizumab in patients with immune-mediated thrombotic thrombocytopenic purpura

  Sunday, June 25, 2023
  18:30 – 19:30 ET